Utility of Multiparametric CT for Identification of High-Risk NAFLD-Reference-Cited by-同舟云学术

Utility of Multiparametric CT for Identification of High-Risk NAFLD

Published:2021-03 Issue:3 Volume:216 Page:659-668
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Lubner Meghan G.¹,Graffy Peter M.¹,Said Adnan²,Watson Rao³,Zea Ryan⁴,Malecki Kyle M.¹,Pickhardt Perry J.¹

Affiliation:

1. Department of Radiology, University of Wisconsin School of Medicine and Public Health, E3/311 Clinical Science Center, 600 Highland Ave, Madison, WI 53792.

2. Department of Internal Medicine, Division of Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI.

3. Department of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.

4. Department of Biostatistics, University of Wisconsin School of Medicine and Public Health, Madison, WI.

Publisher

American Roentgen Ray Society

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://www.ajronline.org/doi/pdf/10.2214/AJR.20.22842

Reference54 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

3. Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016

4. Natural History of Hepatic Steatosis: Observed Outcomes for Subsequent Liver and Cardiovascular Complications

5. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of hepatic and splenic volumetric assessment in imaging for chronic liver disease: a narrative review;Insights into Imaging;2024-06-18

2. Post-contrast CT liver attenuation alone is superior to the liver–spleen difference for identifying moderate hepatic steatosis;European Radiology;2024-06-04

3. Metabolic dysfunction-associated steatotic liver disease: A silent pandemic;World Journal of Hepatology;2024-04-27

4. Multimodality Imaging in Metabolic Syndrome: State-of-the-Art Review;RadioGraphics;2024-03-01

5. Noninvasive evaluation of liver fibrosis in MASLD—Imaging/elastography based;Metabolic Steatotic Liver Disease;2024